Guideline for prescribing vigabatrin in children has been revised. Vigabatrin Paediatric Advisory Group

Guideline

Vigabatrin Paediatric Advisory Group. BMJ. 2000.

. 2000 May 20;320(7246):1404-5.

No abstract available

Comment in

Revised guideline for prescribing vigabatrin in children. Guideline's claim about infantile spasms is not based on appropriate evidence.
Lux AL, Edwards SW, Osborne JP, Hancock E, Johnson AL, Kennedy CR, O'Callaghan FJ, Newton RW, Verity CM. Lux AL, et al. BMJ. 2001 Jan 27;322(7280):236-7. BMJ. 2001. PMID: 11159628 Free PMC article. No abstract available.

Severe persistent visual field constriction associated with vigabatrin.
Eke T, Talbot JF, Lawden MC. Eke T, et al. BMJ. 1997 Jan 18;314(7075):180-1. doi: 10.1136/bmj.314.7075.180. BMJ. 1997. PMID: 9022432 Free PMC article. No abstract available.
Guideline may help in prescribing vigabatrin.
Appleton RE. Appleton RE. BMJ. 1998 Nov 7;317(7168):1322. doi: 10.1136/bmj.317.7168.1322. BMJ. 1998. PMID: 9804738 Free PMC article. No abstract available.

1. Appleton RE. Guideline may help in prescribing vigabatrin. BMJ. 1998;317:1322. - PMC - PubMed
1. Eke T, Talbot JF, Lawden MC. Severe, persistent visual field defect constriction associated with vigabatrin. BMJ. 1997;314:180–181. - PMC - PubMed
1. Wild JM, Martinez C, Reinshagen G, Harding GFA. Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia. 1999;40:1784–1794. - PubMed
1. Harding GFA, Robertson K, Holliday I, Jones L. Field-specific visual-evoked potentials for assessment of peripheral field defect in a paediatric population. J Physiol. 1999;518(P):P171. (abstract). - PubMed
1. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone dysfunction. Neurology. 1998;50:614–618. - PubMed